Posts

Caribou cuts 32% of staff, further purges pipeline to focus on 2 oncology CAR-T prospects

on

Merck KGaA closes in on SpringWorks deal at $3.5B price point

on

Compounding pharmacies dealt a blow in fight over end of semaglutide shortage

on

Thermo Fisher jumps on the US investment bandwagon with $2B in additional spending

on

Halozyme sues Merck over subcutaneous Keytruda as licensing talks fall through

on

FDA puts Vyne in a twist, slapping hold on psoriasis trial over testicular toxicity concerns

on

Guided by data, Mosaic licenses two cancer compounds from Astex

on

Akeso, Summit's PD-1/VEGF bispecific records another pivotal study win in NSCLC

on

Ex-FDA leader joins new initiative designed to fight 'unfortunate reality' of vaccine landscape

on

Sanofi's Altuviiio closing in on blockbuster status, Dupixent sales surge

on

Mercks Gardasil sales sink further amid China market pressure

on

Sanofi, Novartis CEOs lambast EU price control as Trump reportedly weighs drug cost parity with other nations

on

Lotte Bio launches ADC services; Ypsomed to focus on self-injection business

on